Jupiter Wellness Announces its Novel Cannabidiol-Aspartame Combination Treatment JW-100 Significantly Reduces ISGA Score in Eczema saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.
(1)
JW-100 cleared or reduced eczema following 2 weeks of use in half of the subjects in the JW-100 arm of the randomized placebo-controlled study
50% of subjects in the JW-100 arm achieved ISGA clear or almost clear (1 or 2) with at least a 2-grade improvement from baseline after treatment versus 20% and 15% in the CBD-only and placebo arms
Jupiter plans to file IND with the U.S. FDA
JUPITER, FL / ACCESSWIRE / February 17, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced the results of a clinical study to investigate the safety and efficacy of JW-100 its proprietary lotion formulation for the treatment of atopic dermatitis (eczema)
Jupiter Wellness Announces its Novel Cannabidiol-Aspartame Combination Treatment JW-100 Significantly Reduces ISGA Score in Eczema tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.